OOIR: Observatory of International Research

Papers

(The TQCC of Hamostaseologie is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH	156
Factor XI as a Target for New Anticoagulants	58
Platelets and COVID-19	54
Platelet Shape Changes during Thrombus Formation: Role of Actin-Based Protrusions	29
Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom?	26
Ovarian Vein Thrombosis: A Narrative Review	24
Procoagulant Platelets: Mechanisms of Generation and Action	22
Management of Disseminated Intravascular Coagulation in Acute Leukemias	18
Effects and Side Effects of Platelet Transfusion	14
COVID-19 and Cardiac Arrhythmias	13
A Review of FXIa Inhibition as a Novel Target for Anticoagulation	13
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH	13
Anti-inflammatory Strategies in Atherosclerosis	13
Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice	13
Prevention and Management of Thrombosis in BCR/ABL-Negative Myeloproliferative Neoplasms	12
Management of Antithrombin Deficiency in Pregnancy	11
Pulmonary Hypertension and COVID-19	11
An Update on Laboratory Diagnostics in Haemophilia A and B	10
When and How to Combine Antiplatelet and Anticoagulant Drugs?	10
Bleeding Risk Assessment in Patients with Venous Thromboembolism	10
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis	10
Mechanism, Functions, and Diagnostic Relevance of FXII Activation by Foreign Surfaces	9
COVID-19 and Myocarditis: Findings from Cardiac Magnetic Resonance Imaging and Endomyocardial Biopsies	9
Anticoagulation in Pediatric Patients	9
Platelets in Myocardial Ischemia/Reperfusion Injury	9

Functional Roles of the von Willebrand Factor Propeptide	9
Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia	9
Molecular Profiling of Liver Sinusoidal Endothelial Cells in Comparison to Hepatocytes: Reflection on Which Cell Type Should Be the Target for Gene Therapy	8
New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia	8
Fine-Tuning of Platelet Responses by Serine/Threonine Protein Kinases and Phosphatases—Just the Beginning	8
Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)	7
Anticoagulation in Critically Ill Adults during Extracorporeal Circulation	7
Diagnosis of Platelet Function Disorders: A Challenge for Laboratories	7
Extended Half-Life Factor VIII/Factor IX Products: Assay Discrepancies and Implications for Hemophilia Management	7
COVID-19 and the Incidence of Acute Myocardial Injury	7
Emicizumab for All Pediatric Patients with Severe Hemophilia A	7
Platelets and Matrix Metalloproteinases: A Bidirectional Interaction with Multiple Pathophysiologic Implications	6
How the COVID-19 Pandemic Impacts Lives of Life Scientists	6
Interventional Treatment Options in Children with Extracranial Vascular Malformations	6
Venous Thrombosis and SARS-CoV-2	6
Microvascular Skin Manifestations Caused by COVID-19	6
Measuring Fibrinolysis	6
Venous Thromboembolism Issues in Women	6
Nonfactor Therapies: New Approaches to Prophylactic Treatment of Haemophilia	5
Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)—German Practice of Anticoagulation Therapy of Cancer Patients with Thrombosis	5
Bleeding Issues in Women Under Oral Anticoagulation	5
Global Coagulation Testing in Acute Care Medicine: Back to Bedside?	5
The Concept of Thromboinflammation	5
Markers of Hereditary Thrombophilia with Unclear Significance	5
Thromboinflammation as a Driver of Venous Thromboembolism	5
Treatment of Inherited Platelet Disorders: Current Status and Future Options	4
Analysis of an Inherited Dysfibrinogenemia Pedigree Associated with a Heterozygous Mutation in the FGA Gene	4
Celiac Artery Thrombosis and Splenic Infarction as a Consequence of Mild COVID-19 Infection: Report of an Unusual Case	4
Flow Cytometric Assessment of AKT Signaling in Platelet Activation: An Alternative Diagnostic Tool for Small Volumes of Blood	4
Screening for Cancer in Patients with Acute Venous Thromboembolic Disease	4
Assessment and Monitoring of Coagulation in Patients with COVID-19: A Review of Current Literature	4
An Update on Safe Anticoagulation	4
Update on Thrombosis Risk in Patients with Cancer: Focus on Novel Anticancer Immunotherapies	4
Pathogenic Aspects of Inherited Platelet Disorders	4
Do miRNAs Have a Role in Platelet Function Regulation?	4
Insights from the Hereditary Thrombotic Thrombocytopenic Purpura Registry: Discussion of Key Findings Based on Individual Cases from Switzerland	4
Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group	3
Preexisting Chronic Thromboembolic Pulmonary Hypertension in Acute Pulmonary Embolism? A Case Report and Discussion	3
Thrombosis and Dissection of the Abdominal Arteries Associated with Infarcts of Solid Organs in a Patient with COVID-19: A Novel Clinical Entity	3
Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence	3
New Opportunities for Diagnosis and Prognosis of Stroke: The Benefits of Across Border Approaches	3
COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia	3
Cerebral Venous Thrombosis: What's New?	3
Low von Willebrand Disease: A Bleeding Disorder of Unknown Cause?	3
Transgender Medicine and Risk of Venous Thromboembolism	3
Extensive Thromboembolism in a Young Male with Asymptomatic COVID-19 Infection and Heterozygous Factor V Leiden Mutation	3
GTH 2021: simply online … worth experiencing	3
Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation	3
The Current Evidence of Pulmonary Embolism Response Teams and Their Role in Future	3
Potentials of Endothelial Colony-Forming Cells: Applications in Hemostasis and Thrombosis Disorders, from Unveiling Disease Pathophysiology to Cell Therapy	3

100 Years of Thrombotic Thrombocytopenic Purpura: A Story of Death and Life	3
COVID-19 Presented with Deep Vein Thrombosis in a Patient with Paroxysmal Nocturnal Haemoglobinuria	3
Osteoporosis Remains Constant in Patients with Hemophilia—Long-Term Course in Consideration of Comorbidities	3
Anticoagulation in Patients with Platelet Disorders	3
Modulating Autoimmunity against LDL: Development of a Vaccine against Atherosclerosis	3
Inhibition of MicroRNA-122-5p Relieves Myocardial Ischemia-Reperfusion Injury via SOCS1	3
Diagnostic Performance of a Particle Gel Immunoassay in Vaccine-Induced Immune Thrombotic Thrombocytopenia	3
Cancer-Associated Venous Thromboembolism—Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline	3
A Comparison of Activated Partial Thromboplastin Time and Activated Coagulation Time for Anticoagulation Monitoring during Extracorporeal Membrane Oxygenation Therapy	3
Immune Plasma for the Treatment of COVID-19: Lessons Learned so far	3
Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect	3
Flow Chamber Analyses in Cardiovascular Research: Impact of Platelets and the Intercellular Crosstalk with Endothelial Cells, Leukocytes, and Red Blood Cells	3
Communication in Healthcare: Global challenges in the 21st Century	3